GPR30: a novel therapeutic target in estrogen-related disease
- 31 March 2008
- journal article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 29 (3), 116-123
- https://doi.org/10.1016/j.tips.2008.01.001
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patientsThe Breast, 2007
- Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous systemJournal of Endocrinology, 2007
- G Protein-Coupled Receptor 30-Dependent Protein Kinase A Pathway Is Critical in Nongenomic Effects of Estrogen in Attenuating Liver Injury after Trauma-HemorrhageThe American Journal of Pathology, 2007
- G protein-coupled receptor 30 is an estrogen receptor in the plasma membraneBiochemical and Biophysical Research Communications, 2006
- A G-Protein-Coupled Estrogen Receptor Is Involved in Hypothalamic Control of Energy HomeostasisJournal of Neuroscience, 2006
- Cloning of cDNAs Encoding G Protein-Coupled Receptor Expressed in Human Endothelial Cells Exposed to Fluid Shear StressBiochemical and Biophysical Research Communications, 1997
- Identification of a Gene (GPR30) with Homology to the G-Protein-Coupled Receptor Superfamily Associated with Estrogen Receptor Expression in Breast CancerGenomics, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Importance of estrogen sulfates in breast cancerJournal of Steroid Biochemistry, 1989
- Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol redJournal of Steroid Biochemistry, 1988